Floatz logo

Fentanyl

Glucose Intolerance

Pontificia Universidad Catolica de ChileSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Glucose Intolerance cohort.

Asset / SponsorPhaseRating
Dulaglutide
University of Pennsylvania
Phase 4BBB
Vibisone
The University of Texas Health Science Center, Houston
Phase 4BB
Dexmedetomidine
Pontificia Universidad Catolica de Chile
Phase 4BB
Nepenthe
Washington University School of Medicine
Phase 4BB
Candesartan
Fundación Cardiovascular de Colombia
Phase 4BB

View all 15 →

Same molecule, other indications

Fentanyl is also rated in:

chronic pain syndromeActive
BBB
Indicative · Phase 4
74 / 100
View asset →
osteoarthritisDormant
BBB
Indicative · Phase 4
73 / 100
View asset →
substance-related disorderActive
BB
Indicative · Phase 4
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →